3) Trigeminal Nerve Stimulation (tTNS)

is FDA cleared for the treatment of migraine and cluster headaches. It is also being investigated for seizure prevention.

Although the manufacturer states that daily treatment is required for results, we have found that many people experience relief from the first treatment. Instead of giving a prescription and having patients buy a device ($400), wait three weeks to get it and not know if it will work, we do the stimulation in the office. If successful, we can loan a device until the purchased one arrives.

Trigeminal Nerve Stimulation is also being actively investigated for other disorders including:

Seizures (Cook 2015, Soss 2015, Moseley 2014, Zare 2014, Pack 2013, DeGiorgio 2013, DeGiorgio 2009, DeGiorgio 2006, DeGiorgio 2003, Fanselow 2012, Pop 2011), 

Depression (Shiozawa 2015, Cook 2013, Schrader 2011), 

ADHD (McGough 2015), 

Fibromyalgia (Shiozawa 2014), 

PTSD (Trevizol 2015), 

Generalized Anxiety Disorder (Trevizol 2015), 

(in addition to Trigeminal Nerve Stimulation for headache, Transcutaneous Occipital Nerve Stimulation may also offer a way to help provide relief and reduce suffering.)